NM_032864.4:c.516G>C
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_032864.4(PRPF38A):āc.516G>Cā(p.Glu172Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,613,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032864.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRPF38A | ENST00000257181.10 | c.516G>C | p.Glu172Asp | missense_variant | Exon 5 of 10 | 1 | NM_032864.4 | ENSP00000257181.8 | ||
PRPF38A | ENST00000474048.1 | n.304G>C | non_coding_transcript_exon_variant | Exon 3 of 8 | 1 | |||||
TUT4 | ENST00000528457.5 | c.374-4071C>G | intron_variant | Intron 2 of 2 | 3 | ENSP00000432475.1 | ||||
TUT4 | ENST00000527941.5 | n.*68-2925C>G | intron_variant | Intron 3 of 4 | 5 | ENSP00000436810.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251012Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135640
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1460930Hom.: 0 Cov.: 29 AF XY: 0.0000110 AC XY: 8AN XY: 726842
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152122Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.516G>C (p.E172D) alteration is located in exon 5 (coding exon 5) of the PRPF38A gene. This alteration results from a G to C substitution at nucleotide position 516, causing the glutamic acid (E) at amino acid position 172 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at